TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Quick Inventory of Depressive Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Lesions Detected by [68Ga]-NeoBOMB1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Standard Uptake Value (SUV) Mean by Timepoint and Lesion Location
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Evaluation of Percentage of Injected Dose Reaching the Target (TACs) in Tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Device Related Adverse Events Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Device Performance and Integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of acute graft-versus-host disease, grades II-IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of chronic GVHD, moderate and severe (NIH criteria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunogenicity of the vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of the vaccines
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability of the vaccines
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General Cognitive Function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Daily Functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Verbal Fluency and Learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: hematopoietic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Non-exercise activity calorie expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Residual Effect of Triclosan 1% / Isopropyl Alcohol 70%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Effect on Skin Flora Application Process of Antiseptics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve From 0 to 168 Hours (AUC0-168)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of Etanercept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-generated health data capture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular inflammation on FDG PET-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Endothelial function as measured by flow mediated dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Arterial structure and plaque characteristics on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Intra-dialytic concentrations of electrolytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Markers of functional beta cell mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Immune status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of culture positive results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pulmonary blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients requiring no further treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in CRT as measured by Spectralis spectral domain OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy eating behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical activity behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in counselor content adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in counselor therapeutic skillfulness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative changes in cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vertebral body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of device-related adverse events present
Endpoint domain: Adverse events/effects
Primary endpoint: Intramuscular triglyceride use during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sustained Virologic Response at Week 12 (SVR 12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in interstitial fluid pressure in tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcutaneous and blood-gas pO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 hour area under the curve pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abdominal aortic aneurysm maximum orthogonal diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: CVD-related markers of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of physical performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Association of germline genetic variants with lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Symptom response
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Manifest Refractive Spherical Equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage With Treatment Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Morphine Consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Modified Performance-Oriented Mobility Assessment-Gait Subtest (MPOMA-G)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: simulation scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: tPA treatment information form
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Transforming growth factor beta levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height from anesthesiologist's eye to table top
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from 0 to 12 hrs (AUC12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent total systemic clearance (CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 27-hydroxycholesterol (27-OHC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: COVID-19 activity correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with evaluable sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds ratio of subsequent reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: blood volume flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: diameter of popliteal vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Detection of prostate cancer metastasis to lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Physical Performance Test (PPT) Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life is improved compared to baseline
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neurocognition improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: restoration failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MATRICS Consensus Cognitive Battery Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MADRS Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior-posterior translation of the femoral component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Axial rotation of the femoral component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: proportion of patients cured
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Fidelity Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean value of HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm birth before 34 weeks of gestation in singleton pregnancies
Endpoint domain: Mortality/survival
Primary endpoint: Preterm birth before 32 weeks of gestation in twin pregnancies
Endpoint domain: Mortality/survival
Primary endpoint: Clinically Significant Reduction of PPI Usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of PKLR positive participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient survival at 6 months post implant
Endpoint domain: Mortality/survival
Primary endpoint: Number of RA Participants Achieving Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mobility level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to first mobilise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Ventilator Associated Events
Endpoint domain: Adverse events/effects
Primary endpoint: Cell Cycle Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until any documented episode of ATa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients Responding Very Satisfied on Satisfaction With Depression Care Scale (SDCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in frequency of sex after drinking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall Objective Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tenofovir Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tenofovir AUClast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentially expressed genes in circulating immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of TIM-3, LAG3, VISTA and other inhibitory checkpoint molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Angular deviation of virtual implants and actual implant position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proliferation Status of CRC Tumor and Adjacent Normal Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mucosal Apoptotic Status of CRC Tumor and Adjacent Normal Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Dosage of propofol in mg/kg/hr for sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number needed to biopsy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Disposition Index of Glucose Regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Success of Central Venous Cannulation at First Attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Iron level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: C-Reactive Protein level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of sodium channel splicing variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Headache responder rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinical Dementia Rating - Sum of Box Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of hospital days during COPD exacerbation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in vascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change From Baseline Quantitative Myasthenia Gravis (QMG) at 14 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SGI Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of influenza infection
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in Hemoglobin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety as evaluated by assessment of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: health information competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patient satisfaction with their doctor
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dynamics of humoral and cellular immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in imaging parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival (patients with evaluable disease)
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients meeting ACR20 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic Valve Reintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complicated Grief Inventory score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of Tumor Recurrence and Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Smoking cessation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: D-dimer level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seven-category ordinal scale recommended by the WHO
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Auditory Hallucinations Questionnaire (AHQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants With Grade 3 or Higher Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Annual proportion of HIV-infected patients who initiate direct acting antivirals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pedometer-assessed daily steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-minute walking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General health status assessed using PROMIS General Physical and Mental Health-Short Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recommended Phase 2 Dose (R2PD)
Endpoint domain: Adverse events/effects
Primary endpoint: number of patients requiring surgical excision of their facial burns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Annualized rate of acute serious bacterial infections
Endpoint domain: Adverse events/effects
Primary endpoint: Retinal vessel oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of ocular neovascularisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Major Adverse Events or Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Hippocampal volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sinus rhythm in follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participant With Death
Endpoint domain: Mortality/survival
Primary endpoint: Area Under the Curve (AUC) of Hydrochlorothiazide and Amiloride Hydrochloride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Hydrochlorothiazide and Amiloride Hydrochloride in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in stigmatizing attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Margin assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lymph node assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in prevalence and incidence of latent Tuberculosis infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: rate of major postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Self-report Weekly Craving Via Obsessive Compulsive Drinking Scale (OCDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Number of Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Integration of health-relation practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of AMD
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Social vulnerability
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: AAA Related Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Parenting Young Children Scale-Supporting Positive Behavior Sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parenting Stress Inventory - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brief Symptom Inventory-Significant Case Percentage
Endpoint domain: Adverse events/effects
Primary endpoint: Durability of HBeAg seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Compliance with appointment and colonoscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance with scheduled upper endoscopy and colonoscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Physiologic motion pattern of the lower cervical spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Chronic Sinusitis Survey (CSS) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: K-max changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endocrine profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: change in OE importance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in OE accessibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in OE certainty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the curve at steady-state over a 24 hour period (AUC24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants accomplishing FDG-PET guided radiotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Yale Global Tic Severity Scale (YGTSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of malaria infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MOL helpfulness ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of peptide application
Endpoint domain: Adverse events/effects